Literature DB >> 16552038

Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Victor J Torres1, Mark S McClain, Timothy L Cover.   

Abstract

The Helicobacter pylori VacA toxin is an 88-kDa secreted protein that causes multiple alterations in mammalian cells and is considered an important virulence factor in the pathogenesis of peptic ulcer disease and gastric cancer. We have shown previously that a VacA mutant protein lacking amino acids 6 to 27 (Delta6-27p88 VacA) is able to inhibit many activities of wild-type VacA in a dominant-negative manner. Analysis of a panel of C-terminally truncated Delta6-27p88 VacA proteins indicated that a fragment containing amino acids 1 to 478 (Delta6-27p48) exhibited a dominant-negative phenotype similar to that of the full-length Delta6-27p88 VacA protein. In contrast, a shorter VacA fragment lacking amino acids 6 to 27 (Delta6-27p33) did not exhibit detectable inhibitory activity. The Delta6-27p48 protein physically interacted with wild-type p88 VacA, whereas the Delta6-27p33 protein did not. Mutational analysis indicated that amino acids 351 to 360 are required for VacA protein-protein interactions and for dominant-negative inhibitory activity. The C-terminal portion (p55 domain) of wild-type p88 VacA could complement either Delta6-27p33 or Delta(6-27/351-360)p48, reconstituting dominant-negative inhibitory activity. Collectively, our data provide strong evidence that the inhibitory properties of dominant-negative VacA mutant proteins are dependent on interactions between the mutant VacA proteins and wild-type VacA, and they allow mapping of a domain involved in the formation of oligomeric VacA complexes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552038      PMCID: PMC1418911          DOI: 10.1128/IAI.74.4.2093-2101.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.

Authors:  B R Sellman; M Mourez; R J Collier
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

2.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.

Authors:  V Q Nguyen; R M Caprioli; T L Cover
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells.

Authors:  M S McClain; W Schraw; V Ricci; P Boquet; T L Cover
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

5.  Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization.

Authors:  M S McClain; P Cao; T L Cover
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.

Authors:  Y Singh; H Khanna; A P Chopra; V Mehra
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

7.  A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.

Authors:  A D Vinion-Dubiel; M S McClain; D M Czajkowsky; H Iwamoto; D Ye; P Cao; W Schraw; G Szabo; S R Blanke; Z Shao; T L Cover
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

8.  Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA).

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

9.  Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin.

Authors:  Yi Li; Angela Wandinger-Ness; James R Goldenring; Timothy L Cover
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  7 in total

1.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.

Authors:  Mark S McClain; Daniel M Czajkowsky; Victor J Torres; Gabor Szabo; Zhifeng Shao; Timothy L Cover
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

3.  Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.

Authors:  Susan E Ivie; Mark S McClain; Victor J Torres; Holly M Scott Algood; D Borden Lacy; Rong Yang; Steven R Blanke; Timothy L Cover
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

4.  Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin.

Authors:  Melissa G Chambers; Tasia M Pyburn; Christian González-Rivera; Scott E Collier; Ilyas Eli; Calvin K Yip; Yoshimasa Takizawa; D Borden Lacy; Timothy L Cover; Melanie D Ohi
Journal:  J Mol Biol       Date:  2012-11-20       Impact factor: 5.469

5.  A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.

Authors:  Christian González-Rivera; Anne M Campbell; Stacey A Rutherford; Tasia M Pyburn; Nora J Foegeding; Theresa L Barke; Benjamin W Spiller; Mark S McClain; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

6.  Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.

Authors:  Teal M Pelish; Mark S McClain
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

Review 7.  Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy.

Authors:  Farnaz Fahimi; Mohammad Reza Tohidkia; Mehdi Fouladi; Reza Aghabeygi; Naser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.